Proteome-Wide Protein Expression Profiling Across Five Pancreatic Cell Lines

Objectives Mass spectrometry–based proteomics enables near-comprehensive protein expression profiling. We aimed to compare quantitatively the relative expression levels of thousands of proteins across 5 pancreatic cell lines. Methods Using tandem mass tags (TMT10-plex), we profiled the global proteomes of 5 cell lines in duplicate in a single multiplexed experiment. We selected cell lines commonly used in pancreatic research: CAPAN-1, HPAC, HPNE, PANC1, and PaSCs. In addition, we examined the effects of different proteases (Lys-C and Lys-C plus trypsin) on the dataset depth. Results We quantified over 8000 proteins across the 5 cell lines. Analysis of variance testing of cell lines within each data set resulted in over 1400 statistically significant differences in protein expression levels. Comparing the data sets, 10% more proteins and 30% more peptides were identified in the Lys-C/trypsin data set than in the Lys-C–only data set. The correlation coefficient of quantified proteins common between the data sets was greater than 0.85. Conclusions We illustrate protein level differences across pancreatic cell lines. In addition, we highlight the advantages of Lys-C/trypsin over Lys-C–only digests for discovery proteomics. These data sets provide a valuable resource of cell line–dependent peptide and protein differences for future targeted analyses, including those investigating on- or off-target drug effects across cell lines.

[1]  Prasenjit Dey,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[2]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[3]  B. Spiegelman,et al.  Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. , 2015, Cell metabolism.

[4]  Steven P Gygi,et al.  Global Analysis of Protein Expression and Phosphorylation Levels in Nicotine-Treated Pancreatic Stellate Cells. , 2015, Journal of proteome research.

[5]  Bruno Domon,et al.  Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM)* , 2015, Molecular & Cellular Proteomics.

[6]  Alexander S. Banks,et al.  Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10‐plex quantitative proteomics and phosphoproteomics , 2015, Proteomics.

[7]  S. Gygi,et al.  A comprehensive proteomic and phosphoproteomic analysis of yeast deletion mutants of 14‐3‐3 orthologs and associated effects of rapamycin , 2015, Proteomics.

[8]  Damon H. May,et al.  Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma , 2014, Laboratory Investigation.

[9]  Edward L. Huttlin,et al.  MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes , 2014, Analytical chemistry.

[10]  Akhilesh Pandey,et al.  Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics* , 2014, Molecular & Cellular Proteomics.

[11]  Adele Bourmaud,et al.  Technical considerations for large-scale parallel reaction monitoring analysis. , 2014, Journal of proteomics.

[12]  R. Pirola,et al.  Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression , 2014, Front. Physiol..

[13]  M. Donadelli,et al.  Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists , 2013, Electrophoresis.

[14]  Joe R. Cannon,et al.  Mass-biased partitioning to enhance middle down proteomics analysis. , 2013, Journal of mass spectrometry : JMS.

[15]  Anushya Muruganujan,et al.  PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..

[16]  Edward L. Huttlin,et al.  Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. , 2012, Analytical chemistry.

[17]  Derek J. Bailey,et al.  Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.

[18]  Steven P Gygi,et al.  Hyperplexing: A Method for Higher-Order Multiplexed Quantitative Proteomics Provides a Map of the Dynamic Response to Rapamycin in Yeast , 2012, Science Signaling.

[19]  H. Steen,et al.  Mass Spectrometry-Based Proteomics for Translational Research: A Technical Overview , 2012, The Yale journal of biology and medicine.

[20]  H. Steen,et al.  Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS). , 2011, Journal of proteomics.

[21]  H. Steen,et al.  Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs nonproliferating cell states. , 2011, Journal of proteome research.

[22]  P. Spellman,et al.  Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.

[23]  Edward L. Huttlin,et al.  A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression , 2010, Cell.

[24]  Min Zhang,et al.  Membrane proteomic analysis of pancreatic cancer cells , 2010, Journal of Biomedical Science.

[25]  Joe R. Cannon,et al.  High-throughput middle-down analysis using an orbitrap. , 2010, Journal of proteome research.

[26]  J. Shea,et al.  Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.

[27]  Joshua E. Elias,et al.  Target-Decoy Search Strategy for Mass Spectrometry-Based Proteomics , 2010, Proteome Bioinformatics.

[28]  H. Kocher,et al.  Analysis of mortality rates for pancreatic cancer across the world. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[29]  Richard D. Smith,et al.  Does trypsin cut before proline? , 2008, Journal of proteome research.

[30]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[31]  P. Fabri,et al.  HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line , 1994, In Vitro Cellular & Developmental Biology - Animal.

[32]  Steven P Gygi,et al.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.

[33]  J. Kleeff,et al.  Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine , 2005, Laboratory Investigation.

[34]  M. Hollingsworth,et al.  Notch2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells , 2005, Laboratory Investigation.

[35]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[36]  M. Mann,et al.  Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). , 2003, Journal of proteome research.

[37]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[38]  G A Colditz,et al.  A prospective study of cigarette smoking and the risk of pancreatic cancer. , 1996, Archives of internal medicine.

[39]  P. Jekel,et al.  Use of endoproteinase Lys-C from Lysobacter enzymogenes in protein sequence analysis. , 1983, Analytical biochemistry.

[40]  T. Orfeo,et al.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.

[41]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.